Long-term outcomes of combination therapy with methotrexate and methylprednisolone in patients with pulmonary sarcoidosis
I. Merenkova (Kyiv, Ukraine), V. Gavrysyuk (Kyiv, Ukraine), Y. Dziublyk (Kyiv, Ukraine), G. Gumeniuk (Kyiv, Ukraine), N. Pendalchuk (Kyiv, Ukraine), D. Butov (Kharkiv, Ukraine)
Source: International Congress 2022 – Sarcoidosis: challenges in the assessment and management of disease complications
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Merenkova (Kyiv, Ukraine), V. Gavrysyuk (Kyiv, Ukraine), Y. Dziublyk (Kyiv, Ukraine), G. Gumeniuk (Kyiv, Ukraine), N. Pendalchuk (Kyiv, Ukraine), D. Butov (Kharkiv, Ukraine). Long-term outcomes of combination therapy with methotrexate and methylprednisolone in patients with pulmonary sarcoidosis. 3439
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|